Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Avant Immunotherapeutics' CETP vaccine is effective in rabbit models of atherosclerosis

April 20, 1999

SBR-170: a new bioreductive alkylating agent selected for further evaluation

April 20, 1999

News from FASEB: novel botanical product for treatment of Alzheimer's disease

April 20, 1999

BNP-7787 protects against taxane- and platinum-associated neurotoxicity

April 20, 1999

Further phase I data presented for bizelesin at AACR meeting

April 20, 1999

New compound for BPH in active preclinical development at Merck & Co. and Synaptic

April 20, 1999

New frontiers in gene therapy: treatment of erectile dysfunction

April 20, 1999

Recombinant immunotoxin for hematological malignancies from NCI evaluated in phase I

April 20, 1999

Immunological response to GMK melanoma vaccine examined as part of phase III trial

April 19, 1999

News from FASEB: dermal pharmacology of Dekk-Tec's A-007

April 19, 1999

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...